Journal Management System
 
Home  |   Add your Journal  |   Features  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  

TSK Koruyucu Hekimlik Bülteni
TAF Preventive Medicine Bulletin
Periodical of Gulhane Medical Faculty Dpt. of Public Health
Journal Home Page
ISSN: 1303-734X (Print)
Language: [ Turkish ]   [ English ]  
News / Announcements

  » Volume 13, Issue 4
      pp. 273-356
  » Volume 13, Issue 3
      pp. 189-272
  » Volume 13, Issue 2
      pp. 93-188
  » Volume 13, Issue 1
      pp. 1-92

 

Open Access

Review Article



Botulism and Diagnostic Approach

Mehmet Baysallar.

Abstract
Summary
Clostridium botulinum which causes botulism, a neuroparalytic disease, attracts attention recently because of having an important role on classification of biological warfare agents. The diagnosis of botulism is not possible with routine laboratory tests. Culture from stool and food samples or toxin detection from the same samples and sera are preferable procedures. Early diagnosis and supportive treatment are important. Botulism is a notice required disease and its neurological signs are regressive after recovery.This agent which has a much lethal toxin must be considered important and the employee must comply with the biosafety measures during laboratory testing.
Key words: Clostridium botulinum; Botulism; Bacteria, anaerobic; Diagnosis

Key words: Key words: Clostridium botulinum; Botulism; Bacteria, anaerobic; Diagnosis



Botulizm ve Tanısal Yaklaşım

Özet
Özet
Nöroparalitik bir hastalık olan botulizmi oluşturan Clostridium botulinum biyolojik silah sınıflandırmasında yer aldığı için son yıllarda ayrı bir ilgi çekmektedir. Rutin laboratuar testleri ile botulizm tanısını koymak mümkün değildir. Dışkı ve gıdalardan kültür ile aynı örneklerden ve hasta serumundan toksin aranması tercih edilen işlemlerdir. Tedavide erken tanı ve destekleyici tedavi önemlidir. İyileşmeden sonra nörolojik belirtileri geri dönücü olan botulizm ihbarı zorunlu hastalıklardandır. Çok öldürücü toksini olan bu ajanın, göz ardı edilmemesi ve laboratuar analizleri esnasında biyogüvenlik tedbirlerine uyulması gerekmektedir.
Anahtar Kelimeler: Klostridyum botulinum; Botulizm; Bakteri, anaerobik; Tanı

Anahtar Kelimeler: Anahtar Kelimeler: Klostridyum botulinum; Botulizm; Bakteri, anaerobik; Tanı



REFERENCES
1 Caya JG, Agni R, Miller JE. Clostridium botulinum and clinical laboratorian. Arch Pathol Lab Med. 2004; 128(6): 653-662.   [Pubmed]       
 
2 Rega PP, Bork CE, Burkholder-Allen K, Bisesi MS, Gold JP. Single-Breath-Count Test: an important adjunct in the triaging of patients in a mass-casualty incident due to botulism. Prehosp Disaster Med. 2010; 25(3): 219-222.   [Pubmed]       
 
3 Prigent J, Mazuet C, Boquet D, et al. Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A. Plos One. 2010; 5(10): 1-10. http://dx.doi.org/10.1371/journal.pone.0013245   [Pubmed]          [PMC Free Fulltext]    
 
4 Gutzwiller FS, Steffen R, Mathys P, Walser S, Schmid H, Mutsch M. Botulism: prevention, clinical diagnostics, therapy and possible threat. Dtsch Med Wochenschr. 2008; 133(16): 840-845. http://dx.doi.org/10.1055/s-2008-1075658   [Pubmed]       
 
5 Willke Topçu A, Soyletir G, Doganay M. Enfeksiyon Hastaliklari ve Mikrobiyolojisi. I Cilt. Sistemlere Gore Enfeksiyonlar. 3. Baski. Ýstanbul. Nobel Tip Kitabevleri, 2008, p. 1477-1483.
 
6 Willke A. Botulism. Turkiye Klinikleri j Int Med Sci. 2006; 2(28): 106-112.
 
7 Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG. Botulinum toxin as a biological weapon: Medical and public health management. JAMA. 2001; 285(8): 1059-1070. http://dx.doi.org/10.1001/jama.285.8.1059
 
8 Goonetilleke A, Harris JB. Clostridial neurotoxins. J Neurol Neurosurg Psychiatry. 2004; 75: 35-39. http://dx.doi.org/10.1136/jnnp.2004.046102   [Pubmed]          [PMC Free Fulltext]    
 
9 Shapiro RL, Hatheway C, Becher J, Swerdlow DL. Botulism surveillance and emergency response. A public health strategy for a global challenge. JAMA. 1997; 278(5): 433-435. http://dx.doi.org/10.1001/jama.1997.03550050095041
 
10 Eubanks LM, Silhar P, Salzameda NT, et al. Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease. ACS Medicinal Chemistry Letters. 2010; 1(6): 268-272. http://dx.doi.org/10.1021/ml100074s   [Pubmed]          [PMC Free Fulltext]    
 
11 Akçelik M, Ayhan K, Çakir Ý, et al. Food Microbiology and Applications. 2. Baski. Ankara: Sim Matbaacilik Ltd. Þti, 2000, p. 88-92 ve 433-444.
 
12 Turkish Standard. Mamul Gidalar Ýhtisas Grubu. Microbiology–Detection of Clostridium botulinum and identification of spor and toksine types. TS 12812, 2002, p. 2-7.
 
13 Johnson EA, Summanen P, Finegold SM. Clostridium. Eds.: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. 9th ed. Washington DC. ASM Pres, 2007, p. 889-910.
 
14 Ekong T. Immunological detection of botulinum neurotoxins. Anaerobe. 2000; 6(2): 125-127. http://dx.doi.org/10.1006/anae.1999.0322
 
15 Chao H, Wang Y, Tang S, Liu H. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon. 2004; 43(1): 27-34. http://dx.doi.org/10.1016/j.toxicon.2003.10.013   [Pubmed]       
 
16 Fach P, Hauser D, Guillou JP, Popoff MR. Polymerase chain reaction for the rapid identification of Clostridium botulinum type A strains and detection in food samples. J Appl Bacteriol. 1993; 75(3): 234-239. http://dx.doi.org/10.1111/j.1365-2672.1993.tb02771.x
 
17 Szabo EA, Pemberton JM, Desmarchelier PM. Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction. Applied and Environmental Microbiology. 1993; 55(9): 3011-3020.
 
18 Takeshi K, Fujinaga Y, Inoue K, et al. Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by polymerase chain reaction. Microbiol Immunol. 1996; 40(1): 5-11. http://dx.doi.org/10.1111/j.1348-0421.1996.tb03310.x
 
19 Akbulut D, Grant KA, McLauchilin J. Development and application of real-time PCR assays to detect fragments of the Clostridium botulinum type A, B, and E neurotoxin genes for investigation of human foodborn and infant botulism. Foodborn Pathog Dis. 2004; 1(4): 247-257. http://dx.doi.org/10.1089/fpd.2004.1.247   [Pubmed]       
 
20 Akbulut D, Grant KA, McLauchilin J. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J Clin Microbiol. 2005; 43(9): 4342-4348. http://dx.doi.org/10.1128/JCM.43.9.4342-4348.2005   [Pubmed]          [PMC Free Fulltext]    
 
21 Franciosa G, Pourshaban M, Luca AD, Buccino A, Dallapiccola B, Aureli P. Identification of type A, B, E and F botulinum neurotoxin genes and af botulinum neurotoxigenic clostridia by denaturing high-performance liquid chromatography. Applied and Environmental Microbiology. 2004; 70(7): 4170-4176. http://dx.doi.org/10.1128/AEM.70.7.4170-4176.2004   [Pubmed]          [PMC Free Fulltext]    
 
22 Swenson JM, Thornsberry C, McCroskey LM, Hatheway CL, Dowell VR. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. Antimicrobial Agents and Chemotherapy. 1980; 18(1): 13-19. http://dx.doi.org/10.1128/AAC.18.1.13
 
23 Dezfulian M, Dowell VR. Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases. Journal of Clinical Microbiology. 1980; 11(6): 604-609.   [Pubmed]          [PMC Free Fulltext]    
 

How to Cite this Article
Pubmed Style

Baysallar M. [Botulism and Diagnostic Approach]. TAF Prev Med Bull. 2011; 10(3): 343-350. Turkish. doi:10.5455/pmb.20101119041627



Web Style

Baysallar M. [Botulism and Diagnostic Approach]. www.scopemed.org/?mno=1500 [Access: October 25, 2014]. Turkish. doi:10.5455/pmb.20101119041627



AMA (American Medical Association) Style

Baysallar M. [Botulism and Diagnostic Approach]. TAF Prev Med Bull. 2011; 10(3): 343-350. Turkish. doi:10.5455/pmb.20101119041627



Vancouver/ICMJE Style

Baysallar M. [Botulism and Diagnostic Approach]. TAF Prev Med Bull. (2011), [cited October 25, 2014]; 10(3): 343-350. Turkish. doi:10.5455/pmb.20101119041627



Harvard Style

Baysallar, M. (2011) [Botulism and Diagnostic Approach]. TAF Prev Med Bull, 10 (3), 343-350. Turkish. doi:10.5455/pmb.20101119041627



Turabian Style

Baysallar, Mehmet. 2011. [Botulism and Diagnostic Approach]. TAF Preventive Medicine Bulletin, 10 (3), 343-350. Turkish. doi:10.5455/pmb.20101119041627



Chicago Style

Baysallar, Mehmet. "[Botulism and Diagnostic Approach]." TAF Preventive Medicine Bulletin 10 (2011), 343-350. Turkish. doi:10.5455/pmb.20101119041627



MLA (The Modern Language Association) Style

Baysallar, Mehmet. "[Botulism and Diagnostic Approach]." TAF Preventive Medicine Bulletin 10.3 (2011), 343-350. Print.Turkish. doi:10.5455/pmb.20101119041627



APA (American Psychological Association) Style

Baysallar, M. (2011) [Botulism and Diagnostic Approach]. TAF Preventive Medicine Bulletin, 10 (3), 343-350. Turkish. doi:10.5455/pmb.20101119041627



Submit your manuscript
Register
Abstracting & Indexing
Instructions for Authors
Editorial Board
Aims & Scope
About this Journal
Sign up for TOC

ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Mehmet Baysallar
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 1802
Downloaded: 501
Cited: 0




 




» For Authors




Become Reviewer


» Login Area






Follow ScopeMed on Twitter

ScopeMed Home
Job Opportunities/Service Offers
About ScopeMed
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGEYA Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.